BGI’s hereditary risk screening cancer panels target genes previously linked to a predisposition of cancer. Panel selection was based on expert curation of scientific literature and other high quality resources, including formal medical guidelines.
BGI’s Comprehensive Hereditary Cancer Panel provides information on 79 genes associated with 24 different types of hereditary cancer including some of the most commonly occurring cancers such as hereditary breast, ovarian, colorectal, prostate and stomach cancer. BGI detects different alterations including germline SNV, Indels and CNV.
SUITABLE FOR:
Patients suspected of being at increased risk of hereditary cancer
TA TIME:
20 working days
SAMPLE:
Peripheral blood, DNA, Saliva
TECHNOLOGY:
Target region capture, High-throughput sequencing
Hereditary cancers
Female package
Male package
Breast
√
√
Ovarian
√
Prostate
√
Multiple Endocrine Neoplasia
√
√
Thyroid
√
√
Parathyroid
√
√
Neurofibromatosis
√
√
Pheochromocytoma
√
√
Familial Paraganglioma
√
√
Retinoblastoma
√
√
Melanoma
√
√
Chondrosarcoma
√
√
Colorectal
√
√
Pancreatic
√
√
Endometrial
√
Gastric
√
√
Renal
√
√
Bladder
√
√
Gastrointestinal Stromal
√
√
Urothelial Carcinoma
√
√
Tuberous Sclerosis
√
√
Nephroblastoma
√
√
Neuroblastoma
√
√
Nevoid Basal Cell Carcinoma
√
√
Ordering the BGI SENTIS™ Comprehensive Hereditary Cancer Panel is easy.
STEP 1
Physician orders test
STEP 2
Blood or saliva sample collected
STEP 3
Sample shipped to BGI and analyzed
STEP 4
Results sent to physician
